Advertisement

Topics

Fibroblast Growth Factors FGFs - Biotech, Pharma and Life Science Channel

12:31 EDT 24th June 2018 | BioPortfolio

The family of fibroblast growth factors (FGFs) regulates a plethora of developmental processes, including brain patterning, branching morphogenesis and limb development.

Quite a number of FGF-R agonists are in development or even marketed in a range of different indications of tissue repair:

Cancer: FGF/FGFR signalling is important in tumour angiogenesis but studies in the last few years have uncovered increasing evidence that FGFRs are driving oncogenes in certain cancers and act in a cell autonomous fashion to maintain the malignant properties of tumour cells. These observations make FGFRs increasingly attractive as targets for therapeutic intervention in cancer. There is a range of therapeutic strategies currently employed or in development to antagonise de-regulated FGFRs including antibodies and small molecule tyrosine kinase inhibitors.

Cardiovascular Diseases: Fibroblast growth factor-2 (FGF-2 has been shown over the years to exert acute and direct pro-survival effects, irrespectively of whether it is administered before, during or after an ischemic insult to the heart. FGF-2 is also a potent angiogenic protein and a crucial agent for the proliferation, expansion, and survival of several cell types including those with stem cell properties. Human clinical trials have pointed to a good safety record for this protein.

Wound Healing:  Currently, patients are treated by three growth factors: PDGF-BB, bFGF, and GM-CSF, but FGF is shown to have a role in tissue repair, so may lead to novel treatments.

Dental and Bone Tissue Repair: The role of growth factors (GF) in bone repair is widely recognised, particularly for bone morphogenetic proteins (BMPs) and fibroblast growth factor (FGF). GF are usually stored in the extracellular matrix (ECM), but after injury are actively released by ECM, cells and platelets.

Source; Pharmacol Ther. 2010 Jan;125(1):105-17. (De-regulated FGF receptors as therapeutic targets in cancer)

Add the Fibroblast GF News Channel to your RSS reader;

News Articles [4250 Associated News Articles listed on BioPortfolio]

Malignant Pleural Mesothelioma| A Pipeline Analysis Report 2018| Technavio

Technavio has announced their latest pipeline analysis report for malignant pleural mesothelioma. The report comprises an in-depth analysis of the pipeline molecules under investi...

Global Ortho Pediatric Devices Market 2018-2022 | Increase in Development of New Products Boosts Growth | Technavio

Technavio analysts forecast the global ortho pediatric devices market to grow at a CAGR of almost 6% during the period 2018-2022, according to their latest market research ...

Global Beta-carotene Market| Growth Analysis and Forecast| Technavio

The global beta-carotene market is expected to register a CAGR of nearly 4% during the period 2018-2022, according to the latest market research report by Technavio. This pr...

vTv Therapeutics to Present a Poster at the American Diabetes Association’s 78th Scientific Sessions

vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally administered treatments for Alzheimer’s d...

BBS-Bioactive Bone Substitutes Plc: BBS's ARTEBONE® -product as an example in the Manual of classification of medical devices

BBS-Bioactive Bone Substitutes Plc. COMPANY ANNOUNCEMENT 21.6.2018 BBS's ARTEBONE® -product as an example in the Manual of classification of medical devices The European Commission h...

Competitive Intelligence Solution for a Leading Nutraceuticals Manufacturer – Request a Proposal Now - Infiniti Research

Infiniti Research, a global market and customer intelligence solutions provider, has announced the completion of their new competitive intelligence study on the nutraceuticals ind...

MetaStat Presents Positive Data Showing Inhibition of the MENA-pathway Reduces Cancer Cell Dissemination and Paclitaxel Resistance in Aggressive Cancer

Data presented at the AACR Cancer Dormancy and Residual Disease meeting support a novel therapeutic approach to combating the spread of aggressive cancer MetaStat, Inc....

Global Protein Supplements Market 2018-2022| Celebrity Endorsements to Boost Growth| Technavio

Technavio analysts forecast the global protein supplements market to post a CAGR of more than 8% during the forecast period, according to their latest market research repor...

Global Medical Device Manufacturing Outsourcing Market 2018-2022| Increasing M&A Activities to Promote Growth| Technavio

Technavio analysts forecast the global medical device manufacturing outsourcing market to grow to USD 87.289 billion by 2022, according to their latest market research repo...

Mannatech Announces Final Results of Tender Offer

Mannatech, Incorporated ("Mannatech" or the "Company") (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announce...

Events [0 Results]

None

Companies [364 Associated Companies listed on BioPortfolio]

SkyTechSport

SkyTechSport is a team of sports fans and pros, tech geeks and dreamers, who hate physical limitations. Blending their sports competence and technical expertise with a passion and...

WelCan Capital

WelCan Capital invests in high-impact, foundational companies in the cannabis industry. Leveraging a people + purpose + profits approach, WelCan Capital’s mission is to maxim...

Advanced Energy Industries, Inc.

Advanced Energy (Nasdaq: AEIS) is a global leader in innovative power and control technologies for high-growth, precision power solutions for thin films processes and industrial a...

Know Labs, Inc.

Know Labs, Inc. (f/k/a Visualant, Incorporated) is a public company whose shares trade under the stock symbol “KNWN.” The company’s technology directs structured li...

Accent Therapeutics

Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompa...

AmeriHealth Caritas and CleanSlate Centers

AmeriHealth Caritas District of Columbia, a member of the AmeriHealth Caritas Family of Companies, is a Medicaid managed care health plan dedicated to helping members get care, st...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company...

j2 Global, Inc.

j2 Global, Inc. (NASDAQ: JCOM) is a leading internet information and services company consisting of a portfolio of brands including IGN, Mashable, Humble Bundle, Speedtest, PCMag,...

The National Council for Behavioral Health

Rosenberg led the association during a period of extensive growth and rebranding. Under her leadership the National Council has become a powerful policy and advocacy voice for beh...

Supplylogix

Founded in 2010, Supplylogix applications process millions of transactions every day on behalf of nearly 10,000 national and regional retail pharmacies. Supplylogix is a high-grow...

Clinical Trials [5259 Associated Clinical Trials listed on BioPortfolio]

Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections

This study will assess the efficacy and tolerability of two topical regimens (containing cosmetic human fibroblast-derived, physiologically-balanced growth factor combination products (HUL...

Birth Cohort Study of China Medical University

The CMUBCS is a birth cohort study located in Shenyang, China. Its initial aim is to facilitate research on understanding the interplay between genes and environmental factors on disease e...

Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).

This is a multicentre, prospective, study of EGFR )Epidermal Growth Factor Receptor) mutation status in advanced NSCLC (Non-small cell lung cancer)patients (locally advanced and/or metasta...

A Study to Evaluate the Effects of a New Formula on the Growth, Safety and Tolerance of Infants With Growth Failure

This study is a prospective, open-label, multi-site, growth, safety and tolerance study to evaluate a NF (New Formula). A minimum of 45 evaluable infants with confirmed growth failure will...

Characterization of Methylation Pattern in Human Oocytes of Women Undergoing Intracytoplasmic Sperm Injection Treatment

There is increasing evidence that exposure to environmental factors in early development is associated with an increased risk of metabolic and other common diseases. These increased diseas...

Pelvic Floor Symptoms in Women and Men

Rationale: Pelvic floor symptoms (PFS) are prevalent and often impair quality of life. They include micturition problems, defecation problems, pelvic organ prolapse, sexual problems and ge...

CSF1R Inhibitor JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia

This phase II trial studies how well FMS inhibitor JNJ-40346527 works in treating participants with acute myeloid leukemia that has come back or does not respond to treatment. FMS inhibito...

Psychosocial Outcomes and Transition Readiness in Uveitis

It is widely acknowledged that the transition from paediatric to adult health services should be a multidimensional and multidisciplinary process that addresses the medical, psychosocial, ...

Nutrition Therapy in the Immature Infant (ImNuT)

The primary objective of this double-blind randomized study is to assess the effects of an early, enhanced supply of the essential fatty acids (FAs) arachidonic acid (ARA) and docosahexaen...

The Frequency and Risk Factors of Delayed Graft Function

Delayed graft function (DGF) is an important phenomenon after kidney transplantation with direct and indirect implication on graft survival. Although its incidence and risk factors have be...

PubMed Articles [15754 Associated PubMed Articles listed on BioPortfolio]

Baohuoside-I suppresses cell proliferation and migration by up-regulating miR-144 in melanoma.

Baohuoside-I was reported to induce apoptosis in non-small-cell lung cancer and inhibit the growth of multiple myeloma cells. The antitumour potential of baohuoside-I has not been demonstrated in mela...

Singular stochastic control model for algae growth management in dam downstream.

A stochastic control model for finding an ecologically sound, fit-for-purpose dam operation policy to suppress bloom of attached algae in its downstream is presented. A singular exactly solvable and a...

Parents' concerns regarding the growth characteristics of their adolescents: a qualitative inquiry in Iran.

In recent times, parents have become increasingly concerned, both subjectively and objectively, about their adolescents' body height/weight growth. Parent-adolescent interactions about this issue and ...

Risk factors associated with self-reported musculoskeletal pain among short and long distance industrial gas delivery truck drivers.

This study investigated and compared the associations between self-reported exposures to individual as well as work-related physical and psychosocial risk factors for musculoskeletal (MS) disorders an...

A brief overview of the Swi1 prion-SWI+.

Prion and prion-like phenomena are involved in the pathology of numerous human neurodegenerative diseases. The budding yeast, Saccharomyces cerevisiae, has a number of endogenous yeast prions-epigenet...

Enzymatic mitigation of 5-O-chlorogenic acid for an improved digestibility of coffee.

A p-coumaroyl esterase from Rhizoctonia solani was used to decrease 5-O-chlorogenic acid (5-CQA) content in coffee powder. HPLC-UV showed a decline of up to 98% of 5-CQA after the enzyme treatment. Ef...

The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly.

Atrial fibrillation (AF) is the most common arrhythmia and its prevalence increases with age. Age also increases the risk of thromboembolism related to AF. As a result, elderly patients are at increas...

Single-Image Super-Resolution Based on Rational Fractal Interpolation.

This paper presents a novel single-image super-resolution (SR) procedure, which upscales a given low-resolution (LR) input image to a high-resolution image while preserving the textural and structural...

Nutritional practices and adequacy in children supported on extracorporeal membrane oxygenation.

Use of extracorporeal membrane oxygenation (ECMO) in children is increasing. Yet, little is known about optimal nutritional practices in these children. We aim to describe the nutritional adequacy, fa...

Phosphate-solubilizing bacteria improve the phytoremediation efficiency of Wedelia trilobata for Cu-contaminated soil.

In a controlled experiment, we assessed the effect of phosphate-solubilizing bacterium (PSB) on the soil metal (Cu) phytoremediation by Wedelia trilobata and examined the effect of the interaction of ...

Videos

None available.

Medical and Biotech [MESH] Definitions

A fibroblast growth factor receptor with specificity for FIBROBLAST GROWTH FACTORS; HEPARAN SULFATE PROTEOGLYCAN; and NEURONAL CELL ADHESION MOLECULES. Several variants of the receptor exist due to multiple ALTERNATIVE SPLICING of its mRNA. Fibroblast growth factor receptor 1 is a tyrosine kinase that transmits signals through the MAP KINASE SIGNALING SYSTEM.

A family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family.

A fibroblast growth factor receptor that is found in two isoforms. One receptor isoform is found in the MESENCHYME and is activated by FIBROBLAST GROWTH FACTOR 2. A second isoform of fibroblast growth factor receptor 2 is found mainly in EPITHELIAL CELLS and is activated by FIBROBLAST GROWTH FACTOR 7 and FIBROBLAST GROWTH FACTOR 10. Mutation of the gene for fibroblast growth factor receptor 2 can result in APERT SYNDROME.

The most divergent of the known fibroblast growth factor receptors. It does not contain an intracellular TYROSINE KINASE domain and has been shown to interact with FIBROBLAST GROWTH FACTOR 2. Fibroblast growth factor receptor 5 is found primarily in skeletal tissue.

These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesize DNA. The factors are related to both the basic and acidic FIBROBLAST GROWTH FACTORS but have different amino acid sequences.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

review and buy Fibroblast Growth Factors FGFs market research data and corporate reports here

Channels Quicklinks